Host species | Human |
Isotype | Fusion - [FLT1 (fms-related tyrosine kinase 1, vascular endothelial growth factor receptor 1, VEGFR-1, VEGFR, FLT, FRT, vascular permeability factor receptor) domain 2 fragment (132-232) - KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) domain 3 fragment (227-327) - FGFR1 (fibroblast growth factor receptor 1, FLT2, KAL2) domains 2 and 3 fragment (150-361)]2 - IGHG1 Fc (Fragment constant) |
Species reactivity | Human |
Form | Liquid |
Storage buffer | 0.01M PBS, pH 7.4. |
Purity | >95% as determined by SDS-PAGE. |
Clonality | |
Applications | Research Grade Biosimilar |
Target | bFGF, FGF2, Basic fibroblast growth factor, HBGF-2, FGFB, FGF-2, Heparin-binding growth factor 2, Fibroblast growth factor 2, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A |
Purification | Protein A/G purified from cell culture supernatant. |
Endotoxin level | Please contact with the lab for this information. |
Expression system | Mammalian Cells |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternative Names | RC-28,RC28-E,VF-28,VF-Trap-8, CAS: 2363779-14-8 |
Note | For research use only. Not suitable for clinical or therapeutic use. |